Metallothionein III is reduced in Alzheimer’s disease

[1]  R. Tanzi,et al.  Alzheimer's disease, beta-amyloid protein and zinc. , 2000, The Journal of nutrition.

[2]  M. Asanuma,et al.  Antioxidants protect against dopamine-induced metallothionein-III (GIF) mRNA expression in mouse glial cell line (VR-2g) , 2000, Brain Research.

[3]  C. Masters,et al.  Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. , 1999, The Journal of biological chemistry.

[4]  J. Hidalgo,et al.  Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I+II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer's disease brains. , 1999, Journal of neurotrauma.

[5]  A. Larson,et al.  The Distribution of Zinc Selenite and Expression of Metallothionein-III mRNA in the Spinal Cord and Dorsal Root Ganglia of the Rat Suggest a Role for Zinc in Sensory Transmission , 1999, The Journal of Neuroscience.

[6]  R. Romo,et al.  Somatosensory discrimination based on cortical microstimulation , 1998, Nature.

[7]  R. Palmiter,et al.  Metallothioneins in brain--the role in physiology and pathology. , 1997, Toxicology and applied pharmacology.

[8]  P. Fraser,et al.  Sensitive detection of metallothioneins-1, -2 and -3 in tissue homogenates by immunoblotting: a method for enhanced membrane transfer and retention. , 1996, Journal of biochemical and biophysical methods.

[9]  R. Palmiter.  Constitutive expression of metallothionein-III (MT-III), but not MT-I, inhibits growth when cells become zinc deficient. , 1995, Toxicology and applied pharmacology.

[10]  S. Tsuji,et al.  Changes of growth inhibitory factor after stab wounds in rat brain , 1995, Brain Research.

[11]  N. Berman,et al.  Chemical modulation of metallothionein I and III mRNA in mouse brain , 1995, Neurochemistry International.

[12]  S. Tsuji,et al.  Expression of growth inhibitory factor (GIF) in normal and injured rat brains , 1995, Neurochemistry International.

[13]  J. Lancaster,et al.  Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Y. Ihara,et al.  The N-terminal Portion of Growth Inhibitory Factor Is Sufficient for Biological Activity (*) , 1995, The Journal of Biological Chemistry.

[15]  R. Palmiter,et al.  Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[16]  R. Palmiter,et al.  Enhanced neurotrophic activity in Alzheimer's disease cortex is not associated with down-regulation of metallothionein-III (GIF) , 1994, Brain Research.

[17]  P. Hunziker,et al.  Isolation, primary structures and metal binding properties of neuronal growth inhibitory factor (GIF) from bovine and equine brain , 1994, FEBS letters.

[18]  G. Vaula,et al.  Protein-DNA interactions in the promoter region of the amyloid precursor protein (APP) gene in human neocortex. , 1994, Brain research. Molecular brain research.

[19]  P. Chomczyński,et al.  A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. , 1993, BioTechniques.

[20]  R. Palmiter,et al.  MT-III, a brain-specific member of the metallothionein gene family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Titani,et al.  The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein , 1991, Neuron.

[22]  W. Griffin,et al.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Y. Uchida,et al.  Neurotrophic action of Alzheimer's disease brain extract is due to the loss of inhibitory factors for survival and neurite formation of cerebral cortical neurons , 1989, Brain Research.

[24]  Weiming Xia,et al.  Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice , 1997, Nature Medicine.

[25]  N. Bazan,et al.  RNA Message Levels in Normally Aging and in Alzheimer’s Disease(AD)-Affected Human Temporal Lobe Neocortex , 1996 .